PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 113 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $245,000 | +12.9% | 45,369 | +9.3% | 0.02% | +9.5% |
| Q2 2020 | $217,000 | +72.2% | 41,517 | +3.6% | 0.02% | +40.0% |
| Q1 2020 | $126,000 | -13.1% | 40,092 | +11.2% | 0.02% | +15.4% |
| Q4 2019 | $145,000 | -8.2% | 36,046 | -1.1% | 0.01% | -13.3% |
| Q3 2019 | $158,000 | -12.7% | 36,459 | -19.5% | 0.02% | -16.7% |
| Q2 2019 | $181,000 | -55.7% | 45,277 | -40.7% | 0.02% | -59.1% |
| Q1 2019 | $409,000 | -6.8% | 76,330 | -10.7% | 0.04% | -21.4% |
| Q4 2018 | $439,000 | -54.3% | 85,491 | -13.6% | 0.06% | -48.6% |
| Q3 2018 | $960,000 | +260.9% | 98,934 | +279.8% | 0.11% | +230.3% |
| Q2 2018 | $266,000 | +84.7% | 26,050 | +135.7% | 0.03% | +73.7% |
| Q1 2018 | $144,000 | – | 11,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |